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Arythmies supraventriculaires chez les patients adultes porteurs 
d'une cardiopathie congénitale 
Rapport de synthèse 
Mon projet de recherche s'est articulé autour des arythmies supraventriculaires chez les 
patients adultes porteurs d'une cardiopathie congénitale (Adults with Congenital Heart Disease ou 
ACHD). Grâce aux progrès de la chirurgie cardiaque et de la cardiologie, la survie à l'âge adulte des 
enfants nés avec une malformation cardiaque est excellente et la population des ACHD ne cesse de 
croitre, tout en vieillissant. Les arythmies cardiaques sont une complication à long terme bien connue 
chez ces patients et une des principales causes de mortalité et de morbidité. 
Mon travail de recherche comporte une perspective épidémiologique avec une étude de 
population et une perspective anatomique, avec une étude d'imagerie cardiaque par échographie. 
1.Étude épidémiologique : Arythmies auriculaires (AA) chez les patients porteurs d'une 
cardiopathie congénitale. 
Sous le titre anglais A trial Arrhythmias in Adults with Congenital Heart Disease, cette étude a 
été publiée dans le journal américain Circulation. A travers les résultats de cette étude, j'ai 
démontré, pour la première fois dans une aussi grande population, que les AA étaient fréquentes 
chez les patients ACHD, que le risque à long-terme pour ces patients de développer des AA était 
élevé, et que le développement d' AA avait un impact négatif en termes de mortalité, de morbidité et 
d'intervention. 
2. Étude anatomique : Les paramètres échographiques associés à la fibrillation auriculaire (FA) chez 
les patients adultes porteurs d'une cardiopathie congénitale. 
Sous le titre anglais Mirror image atrial dilatation in Adult Patients with Atrial Fibrillation and 
Congenital Heart Disease, cette étude a été publiée dans le journal américain International Journal of 
Cardiology. J'ai démontré dans cette étude que les patients ACHD avec une pathologie isolée du 
coeur gauche présentaient une dilatation progressive de l'oreillette gauche {OG) lorsqu'ils 
développaient de la FA. Chez les patients avec une pathologie isolée du coeur droit, j'ai décrit une 
image« miroir»: l'oreillette droite (OD) était toujours plus grande que l'OG et présentait une 
dilatation progressive lors de FA. Ces résultats soutiennent l'hypothèse que la FA pourrait provenir 
de l'OD dilatée chez les patients ACHD avec une pathologie du coeur droit et ouvrent de nouvelles 
perspectives diagnostiques et thérapeutiques chez ces patients. 
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Atrial Arrhythmias in Adults With Congenital 
Heart Disease 
Judith Bouchardy, MD; Judith Therrien, MD; Louise Pilote, MD, MPH, PhD; 
Raluca Ionescu-lttu, MSc; Giuseppe Martucci, MD; Natalie Bottega, MD; Ariane J. Marelli, MD 
Background-Atria1 arrhythmias increase disease burden in the general adult population. Adults with congenital heart 
lesions constitute a rapidly growing group of patients with cardiovascular disease. We hypothesized that atrial 
arrhythmias increase with age and impair health outcomes in this population. 
Methods and Results-We conducted a population-based analysis of prevalence, lifetime risk, mortality, and morbidity 
associated with atrial arrhythmias in adults with congenital heart disease from 1983 to 2005. In 38 428 adults with 
congenital heart disease in 2005, 5812 had atrial arrhythmias. Overall, the 20-year risk of developing atrial arrhythmia 
was 7% in a 20-year-old subject and 38% in a 50-year-old subject. More than 50% of patients with severe congenital 
heart disease reaching age 18 years developed atrial arrhythmias by age 65 years. In patients with congenital heart 
disease, the hazard ratio of any adverse event in those with atrial arrhythmias compared with those without was 2.50 
(95% confidence interval, 2.38 to 2.62; P<0.0001), with a near 50% increase in mortality (hazard ratio, 1.47; 95% 
confidence interval, 1.37 to 1.58; P<0.001), more than double the risk of morbidity (stroke or heart failure) (hazard 
ratio, 2.21; 95% confidence interval, 2.07 to 2.36; P<0.001), and 3 times the risk of cardiac interventions (hazard ratio, 
3.00; 95% confidence interval, 2.81 to 3.20; P<0.001). 
Co11clusio11s-Atrial arrhythmias occurred in 15% of adults with congenital heart disease. The lifetime incidence increased 
steadily with age and was associated with a doubling of the risk of adverse events. An increase in resource allocation 
should be anticipated to deal with this increasing burden. (Circulation. 2009;120:1679-1686.) 
Key Words: arrhythmia 111 epidemiology 111 heart defects, congenital 111 population 
C ongenital heart disease (CHD) constitutes the most prevalent form of major birth defects and currently 
affects > 1 % of all children.1 Because of improvements in 
diagnosis and treatment, the population of adult patients with 
congenital heart disease (ACHD) is growing and aging. 1 
Arrhythmias play an important role in the management of 
ACHD patients.2- 4 Previous lesion-specific studies3•5- 8 have 
identified atrial flutter, intra-atrial reentry tachycardia, and 
atrial fibrillation as common late sequelae.9-16 Although atrial 
arrhythmias have been well studied in the general adult 
population, 11-19 no population data have been generated in 
ACHD patients. 
Editorial see p 1649 
Clinical Perspective on p 1686 
Our objectives were 3-fold: to determine the overall 
prevalence of atrial atThythmias in ACHD patients in 2005, to 
estimate age-related lifetime risk of developing atrial arrhyth-
mias, and to compare adverse outcomes in individuals with 
and without atrial atThythmias in terms of mortality, morbid-
ity, and need for cardiac interventions. 
Received March 17, 2009; accepted August 3, 2009. 
Methods 
Data Sources 
In Quebec, Canada's second largest province, a unique healthcare 
number is assigned to ail individuals at birth and is systematically 
linked to ail diagnoses, hospitalizations, and health services rendered 
for the du ration of a patient' s life. Administrative databases include 
the physicians' services and drug claims database (Régie de 
1' Assurance Maladie du Québec), the hospital discharge summary 
database (Med-Echo), and the Quebec Health Insurance Board. 
A province-wide, population-based CHD database was created atour 
institution by merging the province's 3 administration databases. 1•20 
During this period, diagnostic codes adhered to the Intematio11al 
C/ass(ficatio11 of Diseases, Ninth Revision (JCD-9). Patients were 
identified with CHD if they had at least 1 diagnostic code for CHD 
and/or a CHD-specific surgical procedure. Provider codes were used 
to select diagnoses made by primary care physicians or cardiovas-
cular medical specialists and procedures performed by cardiovascu-
lar surgeons. Patients were assigned 1 or 2 CHD diagnoses with the 
use of a previously defined hierarchical algorithm.20 CHD severity 
was defined on the basis of anatomie diagnosis20 to include tetralogy 
of Fallot (TOF) and truncus arteriosus, endocardial cushion defects, 
transpositü:m complex, univentricular heart, and hypoplastic left 
heart syndrome as "severe CHD" and the remaining diagnoses as 
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*ln the main analysis, thosc patients were followed as control unlil they devclopcd the cvcnt or until the end of the study, 
regardless whether they developed AA during the follow-up. In sensitivity analysis, these patients were censored at the time 
during follow-up when they developed AA (see Methods: study population and statistical section). 
Figure 1. Study population and design, illustrating the derivation of the study population and cohorts. AA indicates atrial arrhythmia. 
"other CHD lesions" (atrial septal defect; ventricular septal defect; 
patent ductus arteriosus; aortic coarctation; anomalies of the pulmo-
nary artery; congenital tricuspid, pulmonary, mitral, or aortic valve 
disease; anomalies of the great veins; and unspecified congenital 
anomalies of the heart and great vessels). Ali information was 
cross-referenced between outpatient and inpatient data sources, By 
law, attestation of death is sent to the Quebec Health lnsurance 
Board, making documentation of death complete in the database, 
whether it occurs in or out of the hospital. 
The CHD database in the province of Quebec therefore contained 
comprehensive longitudinal, demographic, diagnostic, and therapeu-
tic records of al! patient-linked encounters with the healthcare system 
from January 1, 1983, to December 31, 2005 (inclusive) for al! 
Quebec residents identified with CHD. The study was approved by 
the McGill University Health Centre ethics board and the Quebec 
government agency responsible for privacy of access to information. 
selected specialists (anesthetists, cardiologists, cardiothoracic sur-
geons, emergency doctors, general practitioners, internists, neurolo-
gists, and pediatricians) over the 18-year study period. 
The prevalence of atrial arrhythmias in 2005 was estimated with 
the use of a cohort of CHD patients aged > 18 years and alive on 
J anuary 1 of that year. For estimation of age-related lifetime risk, we 
defined an incidence cohort that included subjects free of atrial 
arrhythmia in January 1, 1988, who were or became adults between 
1988 and 2005. The incidence cohort started in 1988 (ie, 5 years after 
the start of the database) to allow the identification and exclusion of 
prevalent atrial arrhythmia cases from the incidence cohort. Subjects 
in the incidence cohort who developed atrial arrhythmia were 
considered incident atrial arrhythmia cases and were used in the 
calculation of the age-specific lifetime atrial arrhythmia risk. 
For comparison of outcomes in those with and. with~ut atr!al 
arrhythmias, we created a matched outcome cohort m wh1ch atnal 
arrhythmia cases identified in the incidence cohort were matched to 
Study Population non-atrial arrhythmia contrais by age, sex, severity of CHD, a~d 
The study's population cohorts were derived from Quebec's CHD time of the first atrial arrhythmia diagnosis of the case. In the mam 
database (Figure 1). Ali patients were either adults or had turned 18 analysis, controls who developed atrial arrhythmia during the 
years of age during the study period. Patients were included as follow-up were followed as control until they developed the event .or 
having atrial mThythmia if a diagnosis of atrial fibrillation or until the end of the study, regardless of whether they dev.eloped atnal 
intra-atrial reentry tachycardia (ICD-9 code 4273) was made by arrhythmia during the follow-up. In sensitivity analysts, these pa-
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tients were censored at the time during follow-up when they 
developed atrial arrhythmia. We excluded from the cohort 11 atrial 
arrhythmia cases for which a control could not be found. 
Study Design 
The retrospective cohorts were open and followed for a maximum of 
18 years. For the matched-cohort analysis, time zero for each 
case-control pair in this matched cohort design was the time of the 
first atrial arrhythmia diagnosis for the case. Once selected as a 
control, a subject was kept in all analyses as a control, regardless of 
whether he or she subsequently developed atrial arrhythmia 
(n=l372) or not. Once patients received an atrial arrhythmia 
diagnosis, they were considered "cases" even if the arrhythmia was 
paroxysmal and not chronic. 
Outcomes were defined as mortality, morbidity, interventions, and 
the combination of the 3 (any adverse event). Mortality was defined 
as death during follow-up in the matched outcomes cohort. Morbid-
ity was defined as an episode of congestive heart failure and/or 
stroke during the follow-up in the matched outcomes cohort and was 
measured with the use of ICD-9 diagnostic codes in the 2 adminis-
trative databases. Interventions were separated into surgery and 
percutaneous interventions and were identified by procedural billing 
codes in the medical claims database. Surgery was further divided 
into cardiac congenital surgery, cardiac noncongenital surgery (cor-
onary artery bypass grafting), and arrhythmia surgery (ablation 
procedures and device implantation). Adverse event is defined as the 
first occurrence of any of the aforementioned 3 clinical outcomes 
during the follow-up. 
Confounders were defined as clinical diagnoses known to be risk 
factors for atrial arrhythmia and each of the 3 outcomes. These 
included a history of hypertension, coronary artery disease, diabetes 
mellitus, stroke, heart failure, and recent cardiac surgery.21 The 
medical confounders were measured in the 5 years before the time 
zero in the matched outcomes cohort with the use of ICD-9 codes in 
the 2 administrative databases, and recent cardiac surgery was 
measured in the 30 days before time zero with the use of procedure 
claim codes. 
Statistical Analysis 
Descriptive statistics include medians, interquartile ranges, and 
proportions. Prevalence of atrial arrhythmia in the year 2005 (Figure 
1) was measured in the prevalence cohort as the ratio between the 
number of ACHD patients alive in 2005 who had an atrial arrhythmia 
diagnosis from 1983 to 2005 and the total ACHD population alive in 
2005. 
Lifetime cumulative incidence of atrial arrhythmia in ACHD 
patients was calculated in the incidence cohort with the use of the 
Practical Incidence Estimators methodology.22 •23 The Practical Inci-
dence Estimators methodology estimates the lifetime cumulative 
incidence of atrial arrhythmia (ie, cumulative risk of developing 
atrial arrhythmia from a baseline age to age 75 years in patients free 
of atrial arrhythmia at the baseline age) adjusted for competing risk 
of death. We estimated the lifetime cumulative incidence in ACHD 
patients with severe and other lesions from different baseline ages 
(18, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, and 70 years). From these 
analyses, we report the lifetime risks of developing atrial arrhythmia 
and the corresponding 95% confidence intervals (Cls). 
Cox multiple regression analysis was performed with adjustment 
for hypertension, diabetes mellitus, ischemic heart diseases, stroke, 
and heart failure, with 1 mode! for each adverse outcome. Adjust-
ment was not necessary for age, sex, and severity of CHD because 
cases and controls were matched for these variables at the design 
stage. 
The multiple Cox regression analysis was not stratified on the 
matched pair because with administrative databases, no imbalance 
was expected to arise between the exposed and unexposed study 
subjects with respect to Joss of follow-up and/or missing data.24•25 
All confounders adjusted for through modeling were defined a priori 
and kept in the mode! regardless of their statistical significance. The 
proportionality of hazards assomption was tested with the use of the 
- log [log(S(T))] plot, and no violation was detected. From this 
Table 1. Baseline and Clinical Characteristics in 2005 in ACHD 
Patients With and Without Atrial Arrhythmias 
2005 Prevalence Cohort 
AA Adults Non-AA Adults Prevalence, % 
Overall 5812 32 618 15.1 
Sociodemographic 
characteristics 
Median age in 2005, 70 (56-79) 38 (26-56) NA 
y (IQR) 
Severe CHO, n (IQR) 41 (31-56) 28 (23-39) NA 
Male, n (%) 2801 (48) 14 015 (43) 16.6 
Selected underlying CHO 
diagnoses 
Atrioventricular canal 98 1186 7.6 
defect 
TOF/truncus 205 1114 15.5 
arteriosus 
Transposition of the 120 308 28.0 
great arteries 
Univentricular hearts 77 241 24.2 
Ebstein's malformation 37 75 33.0 
of tricuspid 
valve 
Atrial septal defect 1362 5835 18.9 
Ventricular septal 322 6248 4.9 
defect 
Coarctation of the 58 694 7.6 
aorta 
Patent ductus arteriosus 30 596 4.8 
Clinical characteristics 
CHO surgery history, 3062 (53) 4624 (14) NA 
n (%) 
Hypertension diagnosis, 4038 (69) 9597 (29) NA 
n (%) 
Acute myocardial 681 (12) 841 (3) NA 
infarction during a 
hospitalization, n (%) 
Oiabetes mellitus, 1577 (27) 3360 (10) NA 
n (%) 
Baseline and clinical characteristics of the patients in the prevalence cohort 
for the year 2005 and overall prevalence (as percentage) in the prevalence 
cohort as well as prevalence in different cardiac congenital lesions are shown. 
AA indicates atrial arrhythmia; IQR, interquartile range; and NA, not applicable. 
analysis, we report hazard ratios (HRs) for atrial arrhythmia versus 
non-atrial arrhythmia and 95% Cis. A sensitivity analysis was 
performed in which case-control pairs were censored at the time 
when the -:ontrol developed an atrial arrhythmia. All statistical 
analyses were performed with the use of SAS statistical software 
(version 9.1). 
Results 
Baseline Characteristics and Prevalence of 
Atrial Arrhythmia 
The patient' s baseline characteristics and prevalence of atrial 
an-hythmia in different subgroups are presented in Table 1. In 
2005, 38 430 CHD patients were alive, of whom 5812 had 
atrial arrhythmia, con-esponding to an overall prevalence of 
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Table 2. Cumulative Risk of Atrial Arrhythmias in Percentages at Different Ages in Patients With Severn and Other CHO 
Period Risk in 5-Year lntervals, % 
Age, Y 5 10 15 20 25 30 35 40 45 50 Lifetime Risk* (95% Cl) 
severe CHD 
20 3.7 8.4 12.8 18.0 22.7 30.5 37.0 43.3 50.4 57.1 63.0 {58.8-67.2) 
25 4.9 9.5 15.1 20.1 28.3 35.1 41.8 49.2 56.3 62.6 (58.1-67.0) 
30 5.0 10.9 16.3 25.1 32.3 39.5 47.5 55.1 61.8 (57 .1-66.5) 
35 6.3 12.0 21.3 29.1 36.7 45.2 53.2 60.3 (55.3-65.2) 
40 6.2 16.4 24.9 33.2 42.5 51.3 59.0 (53.8-64.3) 
45 11.1 20.3 29.4 39.5 49.1 57.5 (51.8-63.3) 
50 11.0 21.8 33.8 45.2 55.2 (48.6-61.9) 
55 12.5 26.5 39.7 51.3 (44.3-58.5) 
60 16.6 32.4 46.3 (38.3-54.3) 
65 19.6 36.9 (28.3-45.5) 
70 22.7 (14.2-31.2) 
Dther CHD 
20 1.0 2.0 3.4 5.4 8.6 12.9 17.8 23.9 31.0 38.8 46.7 (45.8-67.6) 
25 1.0 2.5 4.5 7.8 12.2 17.1 23.4 30.5 38.4 46.5 (45.6-47.4) 
30 1.5 3.6 6.9 11.4 16.4 22.7 30.0 38.1 46.2 (45.3-47.2) 
35 2.1 5.5 10.1 15.2 21.7 29.1 37.4 45.7 (44.8-46.6) 
40 3.5 8.2 13.4 20.1 27.8 36.2 44.8 (43.9-45.8) 
45 4.9 10.4 17.4 25.5 34.3 43.3 (42.4-44.3) 
50 5.9 13.4 21.9 31.4 41.0 (40.1-42.0) 
55 8.1 17.4 27.7 38.2 (27.2-39.2) 
60 10.4 21.9 33.6 (32.6-34.6) 
65 13.4 26.9 (26.0-27.9) 
70 16.2 (15.7-17.5) 
Lifetime risks for atrial fibrillation in severe and other CHD at selected index ages are shown. 
*Ta age 75 years. 
151/1000. Patients in the atrial arrhythmia population were 
older (median age 70 years old versus 38 in the non-atrial 
arrhythmia population), they had undergone more CHD 
surgeries (53% versus 14% ), and they had more cardiovas-
cular risk factors. Patients with severe CHD in the prevalence 
cohort were younger, with a median age of 30 years, and they 
represented 9% of the overall population as well as 9% of the 
atrial arrhythmia population, with a prevalence of 144/1000. 
Prevalence varied according to lesions, from 48/l 000 in 
patent ductus arteriosus to 330/1000 in Ebstein anomal y. 
Age-Related Lifetime Risk 
Lifetime risks up to age 75 years for atrial arrhythmia in 
severe and other CHD at selected ages are shown in Table 2. 
Overall, the 20··year risk of developing atrial arrhythmia was 
7% in a 20-year-old patient and increased to 38% in a 
55-year-old patient, as shown in Figure 2A. More than 50% 
of patients with severe CHD reaching 18 years of age 
developed atrial arrhythmia by age 65 years (Figure 2B). For 
other CHD patients, the lifetime risk to age 70 was 47%, such 
that nearly 1 in 2 patients with ACHD aged 20 years 
developed atrial arrhythmia by age 70 years (Table 2). 
Outcomes 
ACHD patients with atrial arrhythmia present a significant 
increased risk in all outcomes compared with ACHD patients 
without atrial arrhythmia (Figure 3). The hazard ratio (HR) of 
any adverse event in those with atrial arrhythmia compared 
with those without was 2.50 (95% CI, 2.38 to 2.62; 
P<0.0001), with a near 50% increase in mortality, corre-
sponding to a HR of 1.47 (95% CI, 1.37 to 1.58; P<0.001). 
There was more than double the risk of stroke and heart 
failure with a HR of 2.21 (95% CI, 2.07 to 2.36; P<0.001) 
and 3 times the risk of cardiac interventions with a HR of 3.00 
(95% CI, 2.81 to 3.20; P<0.001). 
In a sensitivity analysis performed to determine the impact of 
censoring cases and controls when they developed atrial arrhyth-
mia, the impact of atrial arrhythmia on outcomes was even 
stronger, with a HR of 2.91 (95% CI, 2.76 to 3.07; P<0.001) for 
any adverse event, 1.88 (95% CI, 1.73 to 2.04; P<0.001) for 
mortality, 2.62 (95% CI, 2.44 to 2.82; P<0.001) for morbidity, 
and 3.85 (95% CI, 3.58 to 4.14; P<0.001) for interventions. 
Discussion 
This population-based study documents the prevalence and 
lifetime risk of atrial arrhytlunia in adults with CHD and 
quantifies their impact on adverse events. In this cohort of 
38 430 adults with CHD, atrial arrhythmias were common, 
with a prevalence of 15.1 %. The prevalence of atrial fibril-
lation in the general population has been measured to be 
between 0.4% and 5.5%,17•26- 29 depending on age. In our 
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A 
100 
60 
40 
20-yr risk from age 55 = 38% 
20 
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relatively young population, with a median age of 42 years in 
2005, the prevalence of atrial arrhythmia was 15.1 %, which is 
nearly 3 times higher than in the general population. 
The prevalence of atrial arrhythmia was measured in 
subgroups of ACHD patients in our population-based CHD 
database and is in agreement with published data from 
lesion-specific clinical studies. In TOF, the reported preva-
lence varied from 2.5% in a Japanese patient population30 to 
>30% in a Dutch patient population. 10 A Canadian retrospec-
tive study from the Toronto Congenital Cardiac Centre 
looking at the prevalence of atrial arrhythmia in TOF reported 
a prevalence of 12%,9 which is comparable to our finding of 
a 15.5% prevalence in patients with TOF. The prevalence of 
atrial arrhythmia in our study was even higher in Ebstein 
anomaly (33.0% ), transposition complex (28.0% ), univentric-
ular heart (24.2% ), and atrial septal defect (18.9% ), consistent 
with reports in the literature.11.13,15,31-33 
In the growing population of adults with CHD, 1 we present 
new knowledge on the lifetime incidence of atrial arrhythmia. 
The risk of atrial fibrillation in the general population has 
been well described in men and women aged >40 years. 17·19 
In the Framingham Heart Study, 19 the lifetime risk of atrial 
fibrillation was 26% for 40-year-old men and 23% for 
58 63 68 73 
40-year-old women. In our study, lifetime risk was calculated 
up to age 75 years and was 63% in 20-year-old patients with 
severe CHD and 47% in 20-year-old patients with other 
forms of CHD. In the Rotterdam study,17 the 20-year risk of 
developing atrial fibrillation was 7% for 55-year-old women 
and 10% for 55-year-old men. In our study, overall, the 
20-year risk of developing atrial arrhythmia was 7% in a 
20-year-old patient and increased to 38% in a 50-year-old 
patient. Strikingly, our findings suggest that 20-year-old 
patients with CHD have a 20-year risk of developing atrial 
arrhythmia equivalent to that of 55-year-old women in the 
general population. These findings support the observation 
that patients with CHD are young patients with aged hearts.34 
We present information quantifying the impact of atrial 
arrhythmia on mortality in ACHD. In the general population, 
atrial fibrillation has been associated with reduced survival, 
most notably in patients with cardiac comorbidities. 18·26,35,36 
In our study, mortality increased within the first year after the 
first diagnosis of atrial arrhythmia, persisting in long-term 
follow-up in ail patient subgroups and in ail age categories, 
increasing the risk of death by nearly 50%. Mortality related 
to sudden death and ventricular arrhythmias has been re-
ported in the general ACHD population,4 ·37 as well as for 
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Figure 3. HR for outcomes in ACHD with 
and without atrial arrhythmias (AA). The HR 
for ail outcomes in patients with atrial ar-
rhythmia compared with patients without is 
shown. Atrial arrhythmia confers an 
increased risk in ail adverse events, repre-
sented by a HR >1. 
HR for AA vs. non·AA (95% Cl) 
specific lesions such as TOF38 or the Fontan procedure.39 
Studies examining the impact of atrial fibrillation or flutter on 
mortality have also shown an increase in mortality, particu-
larly in patients with TOF9·10 or the Fontan procedure, in 
whom it has been linked to thromboembolic death. 39 
In the general population, atrial fibrillation can be risk 
stratified to predict stroke rates.35.36•40 No such data exist in 
the CHD population. The risk of stroke in ACHD patients has 
been described in relation to persistence of shunts and 
paradoxical emboli41 and Eisenmenger complex.42 In this 
study, we demonstrate a >50% increase in the risk of stroke 
in patients with ACHD and atrial arrhythmia compared with 
those with CHD and no atrial arrhythmia. Further studies are 
needed to construct a risk score to refine our understanding of 
the interaction between atrial arrhythmia and CHD-specific 
comorbidities to determine possible benefits of anticoagula-
tion therapy. 
Not surprisingly, the presence of atrial arrhythmia con-
ferred a 2- to 3-fold increased risk of congestive heart failure 
and the occurrence of cardiac intervention in ACHD. These 
data underscore the need to look for hemodynamically 
reversible causes of arrhythmia to maximize precarious ven-
tricular fonction in patients with systemic right ventricles and 
univentricular hearts.43 .44 In patients with TOF, attial arrhyth-
mias have been linked to significant pulmonary regurgita-
tion,9 reflecting the need for timely intervention to protect 
right ventricular function. 45 
The limitations of our study should be noted. This study is 
retrospective and uses administrative databases in which 
diagnoses can be misclassified because of coding errors for 
CHD diagnoses and atrial arrhythmia. Because 4-digit ICD-9 
codes were used, we were not able to distinguish between 
certain subtypes of CHD (eg, complete transposition of great 
arteries and congenitally corrected transposition of the great 
arteries) that have the same 4-digit number (7451). We 
minimized misclassification by using all available data for a 
given subject aged > 18 years, including inpatient, outpatient, 
procedural, and provider information. This was done by 
cross-referencing our data sources among the 3 available 
province-wide administrative databases. Manual audits of 
28% of the raw data were performed to detect and adjust for 
discrepancies between data sources. 1 We were limited by 
billing codes for the diagnosis of atrial arrhythmia because 
there is a single 4-digit ICD-9 code for atrial arrhythmia. 
Thus, we were not able to distinguish between atrial fibrilla-
tion, atrial flutter, and intra-atrial reentrant tachycardia. For 
the same reasons, we could not verify the specificity of the 
atrial arrhythmia diagnosis by ECG. To minimize false-
positive results, we preselected specialists from whom we 
accepted the diagnosis of atrial arrhythmia. Even though we 
may have missed the diagnosis of atrial arrhythmia, this 
would bias our results toward the null hypothesis, strength-
ening our conclusions. Although our target population was 
the CHD population of the entire province of Quebec, we 
may have excluded subjects who failed to corne into contact 
with the healthcare system during the 18 years offollow-up or 
those who may have migrated out of the province. However, 
utilization of health services in Quebec was 80% for the 
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population at large from 1998 to 2004, and we have previ-
ously shown that 87% of adults with CHD used specialist 
services and 51 % were hospitalized from 1996 to 2000. 20 
Migration rates in Quebec suggest that we may have overes-
timated the size of the CHD population by only 0.05%. For 
the matched cohort analysis of outcomes, once selected as a 
control, a subject was kept in all analyses as a control, 
regardless of whether he or she subsequently developed atrial 
arrhythmia. However, the sensitivity analysis performed cen-
soring the case-control pairs at the time when the control 
developed atrial arrhythmia demonstrated that the impact of 
atrial arrhythmia on outcomes was even stronger. This 
suggests that any bias from our study may have been toward 
the null hypothesis. A limitation of our outcomes analysis is 
that subjects who developed atrial arrhythmia later in the 
database were less likely to be treated as cases. However, the 
random selection of the controls within each risk set ensures 
that the depletion of cases is independent of all factors that 
might affect the onset of atrial arrhythmia and/or the out-
comes and thus has minimal impact on the study generaliz-
ability. It must be emphasized that we reported an association 
between atrial arrhythmia and outcomes, but our study was 
not designed to demonstrate that maintaining those patients in 
sinus rhythm would lead to fewer adverse outcomes. We 
reported all-cause mortality rather than cardiovascular mor-
tality. Because atrial arrhythmia is expected to have a higher 
impact on cardiovascular mortality than on other-causes 
mortality, the impact of atrial arrhythmia on cardiovascular 
mortality may be higher than the one we estimated for 
all-cause mortality. The province of Quebec accounts for 
25% of Canada's adults, making our results generalizable to 
the rest of Canada. Although this is not a US-based popula-
tion study, standards of care for CHD patients have largely 
followed North American trends and guidelines, with data 
from this country's largest centers yielding surgical outcomes 
comparable to those of US CHD surgical centers.46•47 
Conclusions 
Heart lesions constitute the most common group of congen-
ital malformations. As this population ages and increases in 
size, acquired cardiovascular risk factors will compound the 
risks associated with atrial arrhythmias. We have provided 
new information, the results of which will inform future 
clinical trials aimed at reducing the morbidity and mortality 
associated with atrial arrhythmias in ACHD. Although 
evidence-based therapy is well established for the treatment 
of atrial fibrillation in the general adult population, data from 
small centers and lesion-specific studies have been insuffi-
cient to provide a basis for risk stratification aimed at 
producing comparable data in patients with CHD. Our study 
will provide a departure point for the generation of such data. 
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CLINICAL PERSPECTIVE 
This is the first population study to analyze lifetime risk of developing atrial arrhythmia in adults with congenital heart 
disease. The population of adults with congenital heart disease is growing and aging, and arrhythmias play a major role 
in the long-tenn follow-up. In a population of >38 000 adults with congenital heart disease, the overall prevalence of atrial 
arrhythmias is 15%, and the lifetime risk of developing atrial arrhythmia ranges between 48% and 63%, depending on the 
severity of the congenital heart disease. This implies that young adults have nearly 1 chance in 2 of developing atrial 
arrhythmia if they reach 75 years of age. This study compares outcomes in those with and without atrial arrhythmia and 
reveals significantly increased adverse outcomes associated with atrial arrhythmia, with a near 50% increase in mortality 
and double the risk of morbidity (stroke or heart failure). In conclusion, chis study provides new, comprehensive data on 
atrial arrhythmias in adults with congenital heart disease, showing that atrial arrhythmias are frequent in this population 
and significantly alter outcomes. From a clinical point of view, these findings underscore the need for close follow-up of 
these patients with special attention to their rhythmic status. 
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Background: Atrial fibrillation (AF) is largely regarded to be initiated from left atrial (LA) dilatation, with sub-
sequent dilatation of the right atrium (RA) in those who progress to chronic AF. We hypothesized that in 
adult patients with right-sided congenital heart disease (CHO) and AF, RA dilatation will predominate with 
subsequent dilatation of the left atrium, as a mirror image. 
Keywords: 
Right atrial dilatation 
Atrial fibrillation 
Congenital heart disease 
Metlwds: Adult patients with diagnosis of right-sided, ASO or left-sided CHO who had undergone an echocar-
diographic study and electrocardiographic recording in 2007 were included. RA and LA area were measured 
from the apical view. AFwas diagnosed from a 12-lead electrocardiogram or Holter recording. A multivariate 
logistic regression mode! was used to identify predictors of AF and linear regression models were performed 
to measure relationship between RA and LA area and AF. 
Results: A total of 291 patients were included in the study. Multivariate analysis showed that age 
(p=0.0001), RA (p=0.025) and LA area (p=0.0016) were significantly related to AF. In patients with 
pure left-sided pathologies, there was progressive and predominant LA dilatation that paralleled the devel-
opment of AF from none to paroxysmal to chronic AF. In patients with pure right-sided pathologies, there 
was a mirror image of progressive and predominant RA dilatation with the development of AF. 
Conclusion: We observed a mirror image atrial dilatation in patients with right sided disease and AF. This may 
provide nove! mechanistic insight as to the origin of AF in these patients and deserves further studying in the 
form of targeted electrophysiological studies. 
Mechanisms underlying development and maintenance of parox-
ysmal, persistent and permanent atrial fibrillation are complex, still 
incompletely understood and need further research [1] but an in-
crease in left atrial (LA) size caused by pressure and/or volume over-
load of the (LA) is a well established echocardiographic predictor for 
developing atrial fibrillation (AF) [2-4]. Atrial dilatation results in 
a trial remodeling [ 5 ], with damaged muscle bundles connections 
[6], local conduction heterogeneities, focal spread of activation [7] 
and increased stretch at the junction of the pulmonary veins and LA 
myocardial tissue [ 8 ]. This acts as triggers and substrate for onset 
and maintenance of AF [5]. Once AF goes from paroxysmal to chronic, 
right atrium (RA) also undergoes progressive dilatation [9]. 
The adult congenital heart disease (ACHD) population is growing 
and getting older [10]. Arrhythmias play an important role in the 
management and outcomes of these patients [ 11-14 ]. Various studies 
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[ 12, 15-18] have identified a trial flutter, intra-atrial reentry tachycar-
dia and AF as being common late sequelae seen in as many as 30% of 
ACHD patients. Interestingly, predominant right-sided pathologies 
are observed in at least one third of the se patients [ 10 ]. 
Experimental animal studies have demonstrated that isolated RA 
stretch and dilatation can, on their own, lead to development of atrial 
fibrillation [19-22]. The relationship of isolated RA dilatation and the 
propensity to develop AF has never been studied in humans. 
We hypothesized that in ACHD with isolated right-sided cardiac 
pathology, RA dilatation would 1) be the predominant lesion, 2) be 
related to the development and the chronicity of AF and 3) be associ-
ated, in CAF, with LA enlargement, developed as a consequence of 
atrial fibrillation. 
1. Methods 
1.1. Study population 
The MAUDE Unit database was searched between April 1st, 2007 and March 31st, 
2008 for all adult patients with repaired or unrepaired pure left or right-sided congen-
ital heart disease (CHD) who had undergone a cardiac ultrasound and an electrocardio-
graphic recording within the same 12 months. Pure left or right-sided lesions were 
defined anatomically as lesions originating in the left or right heart without contralat-
eral sequelae. Left-sided CHD lesions included mitral valve anomalies (mitral valve 
prolapse (MVP), mitral stenosis or insufficiency), aortic valve anomalies (bicuspid 
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aortic valve (BAV) with stenosis or insufficiency) and coarctation of the aorta. Right-
sided CHD lesions included tricuspid valve anomalies (Ebstein's malformation, stenosis 
and insufficiency), pulmonary valve anomalies (stenosis, insufficiency, and atresia), te-
tralogy of Fallot (ToF), Eisenmenger, tricuspid atresia with the Fontan procedure, and 
double chambered right ventricle (DCR). Biatrial disease included patients with atrial 
septal defect {ASD). Patients with a previous atrial switch procedure (Mustard and 
senning) were excluded due to surgical scarring in the atria which can actas a trigger 
for AF [23] independent of atrial dilatation. The study protocol was approved by Re-
search Ethics Board of McGill University Health Centre. 
1.2. Baseline data source 
Baseline data were obtained from the patients' files at the most recent clinical visit 
that correlated to the transthoracic echocardiogram and included sex, age, type of CHD, 
prior cardiac intervention (surgical and catheter-based), risk factors for coronary ar-
tery disease ( diabetes, hypertension), prior Ml, prior stroke, symptoms of heart failure 
assessed by NYHA class, thyroid disease and medication use. 
1.3. Diagnosis of atrial fibrillation 
Patients were separated into three rhythm categories upon chart review. Patients 
were classified as sinus rhythm (SR), paroxysmal atrial fibrillation (PAF) and chronic 
atrial fibrillation (CAF). The diagnosis of atrial fibrillation at any time during follow-
up was made from an electrocardiogram (ECG) or a Holter-recording upon chart re-
view. PAF was defined as an episode of AF documented in the chart with subsequent 
demonstration of reversion to sinus rhythm. CAF was defined as AF documented on 
2:2 ECGs with the patient being in AF at the time of last clinical visit. Persistent AF 
with drugs or direct current cardioversion to sinus rhythm was considered as PAF for 
the purpose of the study. Long-lasting AF and permanent AF were grouped as chronic 
AF. Patients with atrial !lutter were classified as "sinus rhythm" if they had no demon-
strated episode of atrial fibrillation. 
1.4. Eclwcardiographic data 
Data for ail echocardiographic studies were collected retrospectively off-line. 
Echocardiographic studies were done using Vivid 7 dimension 06 echocardiograms 
and were interpreted on EchoPAC reading station (GE Healthcare). Echographie mea-
surements were performed by two skilled investigators {DC andjB) who were blinded 
ta the patient's diagnosis. LA and RA measurements adhered to recently published rec-
ommendations [4,24-27]. LA and RA size measurements were performed from an api-
cal 4-chamber view atthe end of ventricu!ar systole to obtain maximal a trial diameters 
and areas, within 12 months ofHolter monitor or 12-lead e!ectrocardiogram recording. 
1.5. Statistical analysis 
Data analysis was performed using Microsoft Office Excel for Windows, version 
2003 and SAS statistical software version 9.2 {SAS lnstitute Inc .. Cary, NC, USA). 
Descriptive data for continuous variable are expressed as means +/-standard de-
viations {SD) or median with interquartile range (IQR). Values in different groups were 
compared using unpaired Student t-tests, Fisher's exact tests, Wilcoxon and X2 , when-
ever appropriate. A p-value<0.05 was considered statistically significant. 
A multivariate logistic regression mode! with AF as dependent variable was used to 
identify the predictors of AF. Results were reported using odds ratios {ORs) and 95% 
Cls. 
Linear regression analysis were performed in the 3 groups (isolated right-sided 
CHD, ASD, and isolated Ieft-sided CHD), to measure the relationship between RA and 
LA area and AF. Parameter estimate of regression coefficients with 95% Cls were 
reported. 
lnterobserver differences in atrial area were expressed as the mean +/-SD. Pear-
son correlation coefficient was calculated. Interobse1ver variability was expressed as 
the ratio of the SD of the difference and the mean of the two measurements. Interob-
se1ver variability was expressed in percentage. 
2. Results 
2.1. Baseline characteristics 
Over the 12-month study period, 314 ACHO patients were identi-
fied. Twenty three (7%) of them were excluded due to inadequate 
echocardiogram quality. Of the 291 remaining patients, 117 had 
right-sided CHO, 68 had ASO and 106 had left-sided CHO. Baseline 
Patient characteristics, cardiac diagnosis, rhythmic status, co-
morbidities and medications are depicted in Table 1. 
ln patients with ASO, 51 patients (75%) were in sinus rhythm, 11 
(16%) had PAF and 6 (9%) were in CAF. In patients with right-sided 
CHO, 107 patients (91%) were in SR, 8 (7%) had PAF and 2 patients (2%) 
Table 1 
Baseline and clinical characteristics in ACHD patients with ASD, isolated right-sided 
CHD and isolated left-sided CHD. The table depicts the baseline and clinical character-
istics of patients with ASD, right-sided and left-sided CHD. ASD=atrial septal defect: 
CHD = congenital heart disease; AF = atrial fibrillation; BP = blood pressure; 
SD= standard deviation; PS = pulmona1y stenosis; DCRV = double-chambered right 
ventricle; BAV = bicuspid aortic valve; PAF= paroxysmal atrial fibrillation; CAF= chronic 
atrial fibrillation; NYHA=New-York Heart Association; MI=myocardial infarction: 
ARB = angiotensin receptors blockers; RA= right atrium: LA= left atrium. 
Right-Sided 
(n= 117) 
Socio-Demographic Characteristics 
Males{%) 53 {45) 
Median age (range) 31 (18-68) 
Sinus rhythm 30 (18-68) 
Paroxysmal AF 44 {24-65) 
Chronic AF 59 {50-67) 
Mean BP (SD) 129/69 (12/11) 
Cardiac Diagnosis (%) 
ASD 
Tetralogy of Fallot/ 
Truncus arteriosus 
PS 
DCRV 
Tricuspid valve anomalies 
Others 
BAV 
Mitral valve anomalies 
Coarctation of the aorta 
Subaortic stenosis/Shone 
syndrome 
Percutaneous or Surgical 
Repair (%) 
Cardiac Rhythm Status 
NonAF (% 
PAF(%) 
CAF(%) 
Comorbidities 
NYHA class 1-11 {%) 
NYHA class Ill-IV (%) 
Ml 
Stroke 
Diabetes 
Hypothyroidism 
Medication {%) 
Antiplatelet agent 
Coumadin 
ACE inhibitor, ARB 
B-blockers 
Diuretic 
Antiarrhythmic drugs 
Lipid lowering agents 
Calcium channel blockers 
50 (43) 
33 (28) 
11 {9) 
9 (8) 
14 (12) 
91 {78%) 
107 (91) 
8 (7) 
2 (2) 
104 {95) 
5 (5) 
1 (1) 
1 (1) 
0 (0) 
9 (8) 
26 {22) 
18 (15) 
5 (4) 
31 (27) 
9 8) 
7 {6) 
8 (7) 
1 (1) 
Echocardiographic parameters 
RA area (mean cm2 ) 
No AF 17 
AF 26 
LA area ( mean cm2 ) 
NoAF 
AF 
13 
17 
ASD 
(n=68) 
26 {38) 
42 (18-82) 
37 {18-59) 
52 (20-82) 
66 (42-80) 
120/71 {13/9) 
68(100) 
56 {82) 
51 (75) 
11 (16) 
6 (9) 
61 {94%) 
4 (6%) 
1 (1) 
1 {1) 
2 (2) 
4 (6) 
27 (40) 
13 {19) 
4 (6) 
15 (22) 
4 (6) 
9 (13) 
7 {10) 
0 (0) 
16 
23 
15 
23 
Left-Sided 
(n=l06) 
62 (59) 
32 {18-82) 
30 (74-18) 
65 (86-43) 
54 {31-68) 
125/72 (14/9) 
53 (50) 
27 {26) 
15 (14) 
11 (10) 
53 (50) 
98 (92) 
4 (4) 
4 (4) 
92 (94) 
6 (6) 
0 (0) 
2 (2) 
2 (2) 
2 (2) 
14 (13) 
18 (17) 
25 (24) 
29 (27) 
5 (5) 
12 (11) 
8 {8) 
6 (6) 
14 
20 
15 
27 
were in CAF. In patients with left-sided CHO, 98 patients (92%) were in 
SR, 4 patients ( 4%) presented PAF and 4 patients ( 4%) were in CAF. 
There was a female predominance in ASO (62%) and in right-sided 
CHO (55%), but a male predominance in left-sided CHO (59%). 
NYHA class was available in 84% of the patients. Most patients were 
in NYHA class 1 and no patientwas in NYHA class 4. For patients in sinus 
rhythm, 203 patients (86%) were in NYHA class 1, 29 (12%) in NYHA 
class 2 and 5 (2%) in NYHA class 3. For patients in PAF, 17 (74%) were 
in NYHA class 1, 2 (9%) in NYHA class 2 and 4 (17%) in NYHA class 3. 
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Table 2 
Univariate and multivariate analysis. The table depicts the parameters associated with atrial fibrillation by univariate and multivariate analysis. ASD = atrial septal defect; 
CHO= congenital heart disease; AF= a trial fibrillation; SR= sinus rhythm; IQR =inter-quartile range; NYHA= New-York Heart Association; LA= left atrium; RA= right atrium; 
LVEF= left ventricle ejection fraction; RV MPI = right ventricle myocardial performance index; OR= odd ratio; Cl= confidence interval. 
Univariate analysis 
N=291 AFN=35 SR N=255 p-value 
Male(%) 19 (54%) 123 (48%) 0.5019 
Age (Median (IQR)) 56 (42, 66) 26 (20,41) <0.0001 
NYHA (Median (IQR)) 1 (1,3) 1 (1,1) 0.0002 
LA area (Median (IQR)) 18 (15,27) 14 (12,17) <0.0001 
RA area (Median (IQR)) 21 (17,31) 14 (12,18) <0.0001 
LVEF_% (Median (IQR)) 60 (60, 60) 60 (60, 60) 0.1232 
RV MPI (Median (IQR)) 0.21 (0.12, 0.31) 0.15 ( 0.06, 0.26) 0.1777 
Multivariate analysis 
N=291 AFN=35 SR N =255 Multivariate OR 95% Cl. p-value 
Age (Median (IQR)) 56 (42, 66) 26 (20,41) 1.073 (1.039, 1.108) <0.0001 
NYHA (Median (IQR)) 1 (1,3) 1 (1,1) 0.910 (0.418, 1.979) 0.8118 
LA area (Median (IQR)) 18 (15,27) 14 (12,17) 1.153 (1.056, 1.259) 0.0016 
RA area (Median (IQR)) 21 (17,31) 14 (12,18) 1.081 (1.010, 1.156) 0.0250 
For patients in CAF, 4 patients (33%) were in NYHA class 1, 2 (17%) pa-
tients were in NYHA class 2 and 6 patients (50%) were in NYHA class 3. 
RA and LA area were within the norms ( <20 cm2) when in sinus 
rhythm in the 3 groups of CHO. In AF patients, we observed a predom-
inant RA dilatation in right-sided CHO, a biatrial dilatation in ASO, and 
a predominant LA dilatation in Ieft-sided. 
2.2. Logistic regression ana/ysis (Table 2) 
On univariate analysis, NYHA (p = 0.0002 ), age (p <0.0001 ), RA 
(p<0.0001) and LA area (p<0.0001 ), were significantly associated 
with AF. 
On multivariate analysis however, only age (p = 0.0001 ), RA 
(p = 0.025) and LA area (p = 0.0016) significantly predicted AF (see 
Table 2). 
RA area as outcome 
Righi sidcd pathology 
ASD 
PAF 3.73 (·1.14, 8.150) 
CAF 18.05 (8.54. 27.56; 
l'AF2.26(-/.73. 6.215) 
CAF 11.97 (15.37, 17.511,J 
Lefl sidcd pathology 
PAF 0.151 (·3.37, 4.59) 
Cff 9. 78 (6.0/, I 3.55) 
LA area as outcome 
Right sidcd pathology 
ASD 
PAF 1.42 (·l.07. J.91) 
CAF ô.19 (1.32. 11.05) 
l'AF 3. 70 (0.54. 6.85) 
CAF I0.83 (6.42. 15.25/ 
Left sidcd pathology 
PAF /.57 (-3.49, 6.62) 
CAF 20.80 (16.02, 25.59) 
.5 0 
2.3. Linear regression analysis 
On linear regression analysis, depicted in Fig. 1, RA area had the 
strongest association with CAF in right sided pathology, compared 
to ASO and left sided disease. A similar pattern was observed for 
PAF albeit with wider CI. In contrast, LA area had the strongest asso-
ciation with CAF in left sided heart disease compare to ASO and be-
came non significant in right sided heart disease. 
2.4. RA/IA ratio 
With the progression of AF, the observed RA/LA ratio pattern in 
patients with right sided disease was inversed to that observed in 
the left sided disease group (see Fig. 2). Patients with ASOs main-
tained a ratio close to 1 throughout the disease process. 
• 
5 10 15 20 25 30 
Parameter Estimates with 95'Y• C.I. 
Fig. 1. Linear regression analysis. The bar-graph demonstrates the correlation between left and right atrium area and atrial fibrillation in different subgroups. RA= right atrium; 
PAF= paroxysmal atrial fibrillation; CAF: chronic atrial fibrillation; ASD = atrial septal defect. 
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Fig. 2. Mirror image atrial dilatation. Fig. 2 depicts the "Mirror image atrial dilatation" 
as expressed by RA/LA area ratio in fonction of different rhythmic status in right-sided 
CHD, ASD and left-sided CHD. RA= right atrium: LA= left atrium: SR= sinus rhythm; 
PAF=paroxysmal atrial fibrillation; CAF=chronic atrial fibrillation; ASD=atrial sep-
tal defect. 
Mean interobserver difference for atrial area measurements was 
1 mm2 +/-1 mm2 with an interobserver variability was 7%. Interob-
server correlation was good, with a correlation coefficient of 0.95 for 
area (p<0.001 ). 
3. Discussion 
We have demonstrated that in patients with isolated right-sided 
cardiac pathology and CAF, right atrial dilatation has the greatest in-
fluence in the development of AF and predominates over left atrial di-
latation throughout the disease process. In contrast and not 
surprisingly, LA area has the greatest influence in the development 
of CAF in patients with left sided pathology and predominated over 
RA dilatation throughout the disease process. Interestingly, patients 
with ASD behave like biatrial disease with equal contribution of RA 
vs. LA dilatation. 
AF is very prevalent in the aging CHD patient population [14] occur-
ring with a prevalence of up to 30% in certain subgroups [28,29]. Our 
group has recently shown that its mere presence more than doubles 
these patients' morbidity and increases their mortality by 50% [14]. 
Correlations between AF and LA size have been well-described in 
the non-congenital cardiac population [4,30]. Increased LA volume 
has been identified as a risk factor for the development of AF [2], 
the recurrence of AF after catheter ablation [31] or cardioversion 
[30] and as a risk factor in the progression of PAF to CAF [30,32]. Pro-
gressive RA dilatation has also been observed in patients with PAF 
and acquired left-heart disease [33] and has been ascribed to a pas-
sive "resulting effect" of AF [34,35] of the contralateral atrium. In 
this study, we were able to show in our CHD population with isolated 
left-sided cardiac disease that LA dilatation had the greatest influence 
on CAF development and that LA dilatation predominated over RA di-
latation throughout the establishment of AF. A similar trend was also 
seen for PAF but not significant due to the low event rate and the 
Wide Cl. 
By contrast, in our CHD patients with isolated right-sided pathol-
ogies, RA dilatation had the greatest influence on the development 
of CAF with RA dilatation predominating over LA dilatation through-
out the disease process. Again, a similar trend was seen for PAF but 
was not significant due to the low event rate. 
Our findings are concordant with observations made in a rabbit 
mode! of atrial stretch by Ravelli and colleagues [20]. In this animal 
study, the interatrial septum was perforated, and after occlusion of 
the cavai and pulmonary veins, biatrial pressures were increased si-
multaneously by raising the level of an outflow cannula in the pulmo-
na1y artery. For a similar rise in atrial pressure, the right atrial 
effective refractory periods were considerably shorter than on the 
left. The monophasic action potentials significantly decreased and 
the inducibility of atrial fibrillation was more pronounced in the RA. 
In other words, the RA was not only able to initiate AF but did so at 
a much lower threshold of pressure ri se than the LA. Similarly, studies 
done on dogs revealed that saline infusion facilitated the induction of 
AF by stretching the RA [ 19] and that the higher the RA pressure, the 
higher the probability of inducing AF [36]. 
We have also recently published a population-based study show-
ing that patients with right sided CHD not only had a greater life inci-
dence risk of developing AF [37] but did so at a younger age [38], in 
keeping with the theory that the RA is more prone to initiate AF for 
a similar pressure rise or degree of dilatation. 
Interestingly, recent histological studies on human hearts have 
shown similar histologies at the junctions between the RA myocardi-
um and the inferior and superior vena cavae to that of the junction 
between the LA myocardium and the pulmonary veins [39]. 
Furthermore, isolated cases of PAF originating from the superior 
vena cava and RA junction have been reported and have responded 
successfully to radiofrequency catheter ablation of the junction [40]. 
Similarly, case reports of successful treatment of paroxysmal a trial fi-
brillation originating from the inferior vena cava and right a trial junc-
tion have recently emerged [ 41 ]. 
Based on this present study and the aforementioned basic, popula-
tion studies and case reports, one could invoke a mechanistic raie of 
the RA in the initiation of AF in our ACHD patients with isolated 
right-sided cardiac pathology and predominant RA dilatation. Electro-
physiological studies aimed at targeting potential initiating sites of AF 
in ACHD patients with isolated right-sided disease and RA dilatation 
would be the next logical step. 
Contra1y to previous reports [ 42-44] our study would suggest that 
ASDs behave more like a biatrial disease with equal dilatation of both 
the right and left atrium concomitant with the establishment of AF. 
Patients in our ASD group were slightly aider than in the right or 
left lesion group. Contribution of concomitant hypertension or left 
ventricular dysfunction perhaps might have played a role in the LA 
dilatation. 
In our study, NYHA class tends to be correlated to AF, as one would 
expect. However, the correlation failed to reach significance by multi-
variate analysis, probably due to the small number of patients in 
NYHA class > 1. 
3.1. Limitations 
The design of this study was cross sectional so that a "cause and 
effect" relationship between the atrium size and AF could not be 
established. Only a careful longitudinal study with precise recording 
of atrial size and timing of AF initiation would be able to answer 
this question in a definitive manner. 
Holter monitoring was not done routinely on ail of our patients. It 
was only performed when clinically indicated. Asymptomatic PAF 
may have been under-diagnosed. 
4. Conclusions 
The observed predominance of RA dilatation and the mirror image 
pattern of atrial dilatation in patient with right sided heart CHD dis-
ease and AF may provide nove! mechanistic insight as to the origin 
of AF in these patients. Basic electrophysiological studies are now 
needed to !end support to our echocardiographic-driven hypothesis 
of RA dilatation acting as the trigger for AF initiation. 
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